✦ LIBER ✦

Hormone receptor status as an independent variable affecting the survival of advanced breast cancer patients with brain metastases

✍ Scribed by Hakan Harputluoglu; Mustafa Cengiz; Kadri Altundag

Book ID: 118496798
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 39 KB
Volume: 82
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2006.10.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comment on the letter to the editor “Hor

Comment on the letter to the editor “Hormone receptor status as an independent variable affecting the survival of advanced breast cancer patients with brain metastases” (Hakan Harputluoglu et al.)

✍ Rupert Bartsch 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 27 KB

Survival in patients with brain metastas

Survival in patients with brain metastases from breast cancer : The importance of HER-2 status

✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i

The relationship of body weight to respo

The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast

✍ Williams, G; Howell, A; Jones, M 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 642 KB

PCN29 Initial Treatment and Survival Amo

PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status: An Analysis of United States National Registry Data 2000-2009

✍ K. Lang; H. Huang; M. Namjoshi; V. Federico; J. Menzin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

3047 POSTER Resection of the primary tum

3047 POSTER Resection of the primary tumour as an independent prognostic factor for survival in patients with advanced colorectal cancer. CAIRO study of the Dutch Colorectal Cancer Group (DCCG)

✍ M. Koopman; N.F. Antonini; G. Vreugdenhil; O.J.L. Loosveld; A. van Bochove; H.A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

68. Randomized trial between the selecti

68. Randomized trial between the selective aromatase inhibitor formestane (Lentaron) or tamoxifen as first-line hormonal therapy in postmenopausal patients with advanced breast cancer: confirmation of bioequivalence in survival

✍ C.M. Royce; L. Mauriac; R. Pérez Carrion; V. Alberola; F. Calabresi; R.Th. Miche 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB